Ajinomoto to acquire Forge Biologics for $620 million
Ajinomoto to acquire Forge Biologics for $620 million
Ajinomoto to acquire Forge Biologics for $620 million in all-cash deal
19.27BUSD
Type
Common Stock
Exchange
OTCGREY
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
-
CUSIP
-
Sector
Consumer Defensive
Industry
Packaged Foods
Fiscal Year End
March
IPO date
-
Updated At
-
PE Ratio
34.15
PEG Ratio
2.71
Book Value
1,632.34
Dividend Share
74
Dividend Yield
1.35%
Earnings Share
1.12
Wall Street Target Price
131.19
EPS Estimate Current Year
-
EPS Estimate Next Year
-
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
1,465,217,974,272
Gross Profit TTM
425,898,000,000
EBITDA
227,855,007,744
Profit Margin
5.72%
Return On Assets TTM
5.26%
Return On Equity TTM
11.40%
Revenue Per Share TTM
2837.269
Qtly Revenue Growth YOY
7.70%
Diluted Eps TTM
1.12
Qtly Earnings Growth YOY
-9.20%
Trailing PE
34.15
Forward PE
26
Price Sales TTM
0.0132
Price Book MRQ
3.4454
Enterprise Value Revenue
2
Enterprise Value EBITDA
12
106.60
1.66%17.01
0.89%85.79
0.87%106.82
0.66%53.47
0.23%82.14
0.01%29.04
0.00%72.50
-1.83%22.72
-0.87%26.52
-0.41%